Comparative study of gene mutation between Chinese patients with familial and sporadic hypertrophic cardiomyopathy

National Medical Journal of China

Volumn 86, Issue 42, 2006, Pages 2998-3001

  Pan, Guo Zhong ^a   Liu, Wen Ling ^b   Hu, Da Yi ^b   Xie, Wen Li ^b   Zhu, Tian Gang ^b   Li, Lei ^b   Li, Cui Lan ^b   Bian, Hong ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Cardiomyopathy; Genotype; Hypertrophic; Mutation

Indexed keywords

MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; TROPONIN T;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHINESE; COMPARATIVE STUDY; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE LOCATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATION RATE; POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CHINA; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; MYOSIN HEAVY CHAINS; TROPONIN T;

EID: 33846444738     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Maron BJ, Nichols PF, Pickle LW, et al. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol, 1984,53: 1087-1094.
2. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 1988,16:1215-1219.
3. Solomon SD, Geisterfer-Lowerance AA, Vosberg HP, et al. A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-1436, and CRI-L329 on chromosome 14 at q11-q12. Am J Hum Genet, 1990,47:389-394.
4. Watkins H, Rosenzweig A, Hwang DS, et al. Characteristics and prognostic implications of myosin missense mutation in familial hypertrophic cardiomyopathy. N Engl J Med, 1992,326: 1108-1114.
5. Maron RJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation, 1995,92:785-789.
6. Watkins H, McKenna WJ, Thierfelder L, et al. The role of cardiac troponin T and a-tropomyosin mutations in hypertrophic cardiomyopathy. N Engl J Med, 1995,332:1058-1064.
7. Watkins H, Conner D, Thierfelder L, et al. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet, 1995,11:434-437.
8. Fananapazir L. Advances in molecular genetics and management of hypertrophic cardiomyopathy. JAMA, 1999,281:1746-1752.
9. Gruen M, Gautel M. Mutations in P-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C. J Mol Biol, 1999, 286:933-949.
10. Song L, Zou Y, Wang J, et al. Mutations profile in Chinese patients with hypertrophic, cardiomyopathy. Clin Chim Acts, 2005,351: 209-216.
11. Chinese source. 2005,14:31-34.
12. Hwang DS, Cben YT, Su JS, et al. Evidence of genetic heterogeneity of hypertrophic cardiomyopathy in eight Chinese patients. Med J China (Taipei), 1996,57:315-321.